WeightWatchers jumps after revealing access to Novo's Wegovy

WW International

08/10/2024 14:29

** Shares of WW International  WW.O , also known as
WeightWatchers, jump ~20% to 95 cents premarket after co says
adding compounded version of Novo Nordisk's  NOVOb.CO  obesity
drug Wegovy to its offering
    ** New offering starting at $129, broadening eligible
members’ access to clinical weight management interventions, co
says
    ** Last month, co named Tara Comonte as interim CEO,
replacing Sima Sistani, who was CEO since Feb 2022
    ** Through Mon, WW shares have shed about 90% in 2024 due to
concerns around co's growth prospects and liquidity
    ** Stock, which at its peak traded just north of $100 in
2018, fell below $1 on Aug 1

 (Lance Tupper is a Reuters market analyst. The views expressed
are his own)
 ((lance.tupper@thomsonreuters.com
lance.tupper@tr.com 1-646-279-6380))